α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease

AIM: Antioxidant therapy for with vitamin E appears to be effective for the treatment of nonalcoholic fatty liver disease　(NAFLD). However, the mechanism of action and optimal therapeutic dosage is unclear. The present study was undertaken to examine whether the effects of α‐tocopherol (α‐Toc) on NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokoro, Masanori, Gotoh, Koro, Kudo, Yoko, Hirashita, Yuka, Iwao, Masao, Arakawa, Mie, Endo, Mizuki, Oribe, Junya, Masaki, Takayuki, Honda, Koichi, Kakuma, Tetsuya, Seike, Masataka, Murakami, Kazunari, Shibata, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909598/
https://www.ncbi.nlm.nih.gov/pubmed/33680496
http://dx.doi.org/10.1002/osp4.460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909598/
https://www.ncbi.nlm.nih.gov/pubmed/33680496
http://dx.doi.org/10.1002/osp4.460

Ejemplares similares